Cavedini P, Erzegovesi S, Ronchi P, Bellodi L
Ospedale San Raffaele, Department of Neuropsychiatric Sciences, University of Milan School of Medicine, Italy.
Eur Neuropsychopharmacol. 1997 Feb;7(1):45-9. doi: 10.1016/s0924-977x(96)00382-3.
Previous reports have stressed the implication of Personality Disorders as predictors of a poorer treatment outcome in Obsessive-Compulsive Disorder (OCD). The aim of this study was to see whether or not Obsessive-Compulsive Personality Disorder in Obsessive-Compulsive Disorder may be predictive for a poorer outcome to antiobsessive pro-serotonergic pharmacological treatment. For this purpose, 30 OCD patients were divided into two groups according to the presence or absence of Obsessive-Compulsive Personality Disorder. Ten-week standardized treatments with oral SRI drugs were given to look for different outcomes between the two groups in Obsessive-Compulsive symptom severity. At the end of the study we found that the presence of Obsessive-Compulsive Personality Disorder, along with the total number of Personality Disorders, did predict poorer response to pharmacological treatment in OCD.
先前的报告强调了人格障碍作为强迫症(OCD)治疗效果较差的预测因素的影响。本研究的目的是探讨强迫症中的强迫型人格障碍是否可预测抗强迫性5-羟色胺能药物治疗效果较差。为此,30名强迫症患者根据是否存在强迫型人格障碍分为两组。给予口服5-羟色胺再摄取抑制剂(SRI)药物进行为期十周的标准化治疗,以寻找两组在强迫症状严重程度方面的不同结果。在研究结束时,我们发现强迫型人格障碍的存在以及人格障碍的总数确实可预测强迫症患者药物治疗反应较差。